Beida Pharmaceuticals: The company is actively promoting the overseas commercial plan for Enzalutamide.

On July 4th, Betta Pharmaceuticals stated on the interactive platform that the company is currently stepping up its efforts to promote the overseas commercial plan for Enzalutamide, actively exploring promotion models that are in line with local regulations and market demands in order to achieve the accessibility of the medicine and maximize the company's interests.